Therapeutic Assessment of Primaquine for Radical Cure of Plasmodium vivax Malaria at Primary and Tertiary Care Centres in Southwestern India

목차 (Table of Contents)

• Abstract
• INTRODUCTION
• MATERIALS AND METHODS
• RESULTS
• DISCUSSION
• REFERENCES

참고문헌 (Reference)

1 WHO, "World Malaria Report 2014" World Health Organization 2014

2 WHO, "World Malaria Report 2013" World Health Organization 2013

3 Saravu K, "Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from primary care centres in southwestern India" 11 : e0157666-, 2016

4 Rishikesh K, "Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India" 14 : 310-, 2015

5 Rishikesh K, "Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India" 14 : 310-, 2015

6 Rishikesh K, "Surmised total leucocyte counts miscalculate the parasite index of Plasmodium vivax malaria patients of tertiary and primary care settings in South-Western India" 14 : 163-, 2015

7 Adak T, "Studies on the Plasmodium vivax relapse pattern in Delhi, India" 59 : 175-179, 1998

8 Srivastava HC, "Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat" 33 : 173-179, 1996

9 Saravu K, "Severity in Plasmodium vivax malaria claiming global vigilance and exploration-a tertiary care centre-based cohort study" 13 : 304-, 2014

10 Saravu K, "Risk factors and outcomes stratified by severity of acute kidney injury in malaria" 9 : e90419-, 2014

11 Gogtay NJ, "Relapse pattern of Plasmodium vivax in Mumbai : a study of 283 cases of vivax malaria" 48 : 1085-1086, 2000

12 Rishikesh K, "Primaquine treatment and relapse in Plasmodium vivax malaria" 110 : 1-8, 2016

13 World Health Organization, "Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria. WHO Evidence Review Group meeting report" 2015

14 Adak T, "Plasmodium vivax polymorphism in a clinical drug trial" 8 : 891-894, 2001

15 Directorate of National Vector Borne Disease Control Programme, "National Drug Policy on Malaria. 22-Shamnath Marg, Delhi-110054: Directorate General of Health Services"

16 Snounou G, "High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction" 61 : 315-320, 1993

17 Kim JR, "Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata" 7 : e39645-, 2012

18 Sinha S, "Efficacy of 5 day radical treatment of primaquine in Plasmodium vivax cases at the BHEL Industrial Complex, Hardwar (UP)" 26 : 83-86, 1989

19 Gogtay N, "Efficacies of 5-and-14-day primaquine regimens in the prevention of relapses in Plasmodium vivax infections" 93 : 809-812, 1999

20 White NJ, "Determinants of relapse periodicity in Plasmodium vivax malaria" 10 : 297-, 2011

21 Saravu K, "Determinants of mortality, intensive care requirement and prolonged hospitalization in malaria-a tertiary care hospital based cohort study from South-Western India" 13 : 370-, 2014

22 Doolan DL, "Acquired immunity to malaria" 22 : 13-36, 2009

23 World Health Organization, "A practical handbook--Management of severe malaria. 3rd ed"